+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Prognostic value of adiponectin in coronary artery disease: Role of diabetes and left ventricular systolic dysfunction



Prognostic value of adiponectin in coronary artery disease: Role of diabetes and left ventricular systolic dysfunction



Diabetes Research and Clinical Practice 118: 58-66



Adiponectin (AD) promotes insulin sensitivity and has anti-atherogenic properties. However, the role of AD on clinical outcomes in coronary artery disease (CAD) is controversial. We analyzed whether AD was an independent predictor of all-cause mortality and hospitalization in patients with CAD. We prospectively enrolled 138 patients with stable CAD, with or without type 2 diabetes and with or without left ventricular dysfunction. A telephone follow-up was conducted to register long term outcomes. Sensitivity/specificity ratio for AD was investigated with ROC analysis and the independent role of AD on outcome was evaluated with Cox regression model of analysis. The survival rate was represented by Kaplan Meyer curves. Of 138 patients, 61 had type 2 diabetes and 71 left ventricular systolic dysfunction (EF<40%). Median time of follow-up was 1384days; mortality rate was 18.8% (26 deaths) and hospitalization rate was 47.1% (65 events). Mean concentration of AD was 9.87±7.53ng/ml; the analysis of the ROC curve identified an AD cut-off level of 13.2ng/ml (AUC 0.779; p<0.0001). Patients with AD >13.2ng/ml had a significantly higher risk of death (HR=6.50; 95% CI: 2.40-17.70), but not of cardiovascular hospitalization (HR=0.87; 95% CI: 0.31-2.44). AD predictivity remained significant also in patients with type 2 diabetes and with left ventricular systolic dysfunction. In stable CAD, an AD value of >13.2ng/ml independently predicts a 6-fold increased risk of all-cause mortality.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 058637607

Download citation: RISBibTeXText

PMID: 27344545

DOI: 10.1016/j.diabres.2016.04.003


Related references

Prognostic value of exercise echocardiography in patients with left ventricular systolic dysfunction and known or suspected coronary artery disease. American Heart Journal 160(2): 301-307, 2010

Prognostic value of exercise-induced left ventricular systolic dysfunction in hypertensive patients without coronary artery disease. Revista Espanola de Cardiologia 68(2): 107-114, 2015

Prognostic significance of exercise training of moderate intensity in patients with coronary artery disease and left ventricular systolic dysfunction. Circulation 94(8 Suppl. ): I327, 1996

Left atrial systolic function during dobutamine stress in coronary artery disease The effect of left ventricular ischemia and left ventricular dysfunction. Journal of the American College of Cardiology 33(2 Suppl. A): 420A-421A, 1999

Relation of coronary artery disease and left ventricular systolic dysfunction to left ventricular end-diastolic pressure after left ventriculography. American Journal of Cardiology 55(13 Pt 1): 1622-1623, 1985

Prognostic value of left atrium dilatation in patients with left-ventricular systolic dysfunction undergoing coronary artery bypass grafting. European Heart Journal 24(Abstract Suppl.): 288, August-September, 2003

Rationale and design of a randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease and left ventricular systolic dysfunction: the morBidity-mortality EvAlUaTion of the I(f) inhibitor ivabradine in patients with coronary disease and left ventricULar dysfunction (BEAUTIFUL) study. American Heart Journal 152(5): 860-866, 2006

Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial. Lancet 372(9641): 817-821, 2008

The worrisome liaison between left ventricular systolic dysfunction and mitral annulus calcification in type 2 diabetes without coronary artery disease: data from the SHORTWAVE study. Nutrition Metabolism and Cardiovascular Diseases 23(12): 1188-1194, 2013

Left ventricular diastolic function in patients with left ventricular systolic dysfunction due to coronary artery disease and effect of nicardipine. American Journal of Cardiology 67(9): 823-829, 1991

Accuracy of advanced versus strictly conventional 12-lead ECG for detection and screening of coronary artery disease, left ventricular hypertrophy and left ventricular systolic dysfunction. Bmc Cardiovascular Disorders 10: 28, 2010

Prognostic Role of Left Ventricular Dysfunction in Patients With Coronary Artery Disease After an Ambulatory Cardiac Rehabilitation Program. American Journal of Cardiology 124(3): 355-361, 2019

Prognostic value of stress myocardial perfusion imaging in patients with mildly impaired systolic left ventricular function or left ventricular asynergy without chest pain but with suspected coronary artery disease. Circulation Journal 70(6): 762-767, 2006

Prevalence of unsuspected mitral regurgitation and left ventricular diastolic dysfunction in patients with coronary artery disease and acute pulmonary edema associated with normal or depressed left ventricular systolic function. American Journal of Cardiology 67(1): 37-41, 1991

Left ventricular dilatation. Prognostic value in severe left ventricular dysfunction secondary to coronary artery disease. Chest 88(2): 215-220, 1985